enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in enVVeno Medical Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −4 vs. Q4 2022
- Shares held
- 1.81M
- +152.8K (+9.2%) vs. Q4 2022
- Total value
- $8.50M
- +$36.6K (+0.4%) vs. Q4 2022
- New holders
- 1
- 6 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $953.6K |
| Q1 2026 | 17 | $1.02M |
| Q4 2025 | 36 | $2.10M |
| Q3 2025 | 36 | $5.40M |
| Q2 2025 | 37 | $20.3M |
| Q1 2025 | 31 | $9.61M |
| Q4 2024 | 35 | $12.9M |
| Q3 2024 | 36 | $17.5M |
| Q2 2024 | 26 | $17.3M |
| Q1 2024 | 32 | $19.8M |
| Q4 2023 | 30 | $21.8M |
| Q3 2023 | 24 | $10.4M |
| Q2 2023 | 23 | $5.90M |
| Q1 2023 | 18 | $8.50M |
| Q4 2022 | 22 | $8.46M |
| Q3 2022 | 22 | $13.7M |
| Q2 2022 | 21 | $8.11M |
| Q1 2022 | 21 | $13.0M |
| Q4 2021 | 24 | $13.7M |
| Q3 2021 | 16 | $8.74M |
| Q2 2021 | 14 | $6.16M |
| Q1 2021 | 16 | $5.24M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding enVVeno Medical Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Newbridge Financial Services Group, Inc. | 20 | $94 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,559 | $7.00K | 0.00% | −299−16.1% | Reduced |
| Wells Fargo & Company | 2,060 | $9.64K | 0.00% | +10.0% | Added |
| Financial Perspectives, Inc | 3,278 | $15.3K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 3,484 | $16.3K | 0.00% | +3,483+348,300.0% | Added |
| Advisor Group Holdings, Inc. | 11,415 | $53.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,074 | $79.9K | 0.00% | +697+4.3% | Added |
| State Street Corp | 21,500 | $101.7K | 0.00% | 00.0% | Unchanged |
| Arthur M. Cohen & Associates, LLC | 24,000 | $112.3K | 0.03% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 24,004 | $113.5K | 0.00% | +2,511+11.7% | Added |
| Morgan Stanley | 28,904 | $135.3K | 0.00% | −1,526−5.0% | Reduced |
| BlackRock Inc. | 34,452 | $161.2K | 0.00% | +642+1.9% | Added |
| Susquehanna International Group, LLP | 43,192 | $204.3K | 0.00% | +5,232+13.8% | Added |
| Geode Capital Management, LLC | 83,083 | $393.0K | 0.00% | 00.0% | Unchanged |
| UBS Oconnor LLC | 177,610 | $840.1K | 0.02% | +177,610 | New |
| Kingdon Capital Management, L.L.C. | 219,180 | $1.03M | 0.24% | 00.0% | Unchanged |
| Vanguard Group Inc | 335,797 | $1.57M | 0.00% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 781,615 | $3.66M | 0.11% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,087−100.0% | Sold out |
| Sepio Capital, LP | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| EWG Elevate Inc. | 0 | $0 | 0.00% | −315−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −10−100.0% | Sold out |